PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Metastatic Breast Cancer 9,288 Disease Target Urokinase-Type Plasminogen Activator 3,939 13 0.00 -1.00 0.00 0.61
Abacavir Sulfate 41 Drug Target Bivalirudin 891 1 0.01 -0.99 0.02 0.68
Metastatic Breast Cancer 9,288 Disease Target Antithrombin 13,773 3 0.00 -1.00 0.00 0.52
Metastatic Breast Cancer 9,288 Disease Target Aurora Kinase A 196 1 0.00 -1.00 0.01 0.59
Metastatic Breast Cancer 9,288 Disease Target Alpha-1 AntiChymotrypsin 1,460 2 0.00 -1.00 0.00 0.57
Metastatic Breast Cancer 9,288 Disease Target Sphingomyelinase 3,060 1 0.00 -1.00 0.00 0.53
Metastatic Breast Cancer 9,288 Disease Target C7 7,027 1 0.00 -1.00 0.00 0.51
Metastatic Breast Cancer 9,288 Disease Target Exendin-4 855 1 0.00 -1.00 0.00 0.56
Sleep Apnea 18,342 Disease Target Endoglin 1,333 2 0.00 -1.00 0.00 0.55
Metastatic Breast Cancer 9,288 Disease Target Carbonic Anhydrase 9 150 2 0.00 -0.99 0.01 0.61
Metastatic Breast Cancer 9,288 Disease Target Cox-2 21,583 29 0.00 -1.00 0.00 0.58
Metastatic Breast Cancer 9,288 Disease Target CD95 4,266 1 0.00 -1.00 0.00 0.52
Metastatic Breast Cancer 9,288 Disease Target CXCL9 1,016 3 0.00 -1.00 0.00 0.59
Metastatic Breast Cancer 9,288 Disease Target Collagen 138,882 54 0.00 -1.00 0.01 0.54
Sleep Apnea 18,342 Disease Target bFGF 9,327 1 0.00 -1.00 0.00 0.49
Metastatic Breast Cancer 9,288 Disease Target CD146 729 1 0.00 -1.00 0.00 0.56
Metastatic Breast Cancer 9,288 Disease Target FABP1 90 1 0.00 -0.99 0.01 0.60
Metastatic Breast Cancer 9,288 Disease Target BMP-7 1,112 2 0.00 -1.00 0.00 0.57
Sleep Apnea 18,342 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 3 0.00 -1.00 0.00 0.57
Metastatic Breast Cancer 9,288 Disease Target ERK2 3,287 5 0.00 -1.00 0.00 0.58
Metastatic Breast Cancer 9,288 Disease Target ETS1 539 2 0.00 -1.00 0.00 0.59
Metastatic Breast Cancer 9,288 Disease Target B2M 677 1 0.00 -1.00 0.00 0.57
Metastatic Breast Cancer 9,288 Disease Target AKT3 293 1 0.00 -1.00 0.00 0.58
Metastatic Breast Cancer 9,288 Disease Target Eotaxin 2,457 1 0.00 -1.00 0.00 0.54
DAPK1 205 Target Target CXCL10 2,386 1 0.00 -1.00 0.00 0.63
Metastatic Breast Cancer 9,288 Disease Target C5a 4,164 1 0.00 -1.00 0.00 0.52
Metastatic Breast Cancer 9,288 Disease Target Angiotensin Converting Enzyme 31,674 1 0.00 -1.00 0.00 0.47
Des (1-6) IGF-II 18 Target Target Urokinase-Type Plasminogen Activator 3,939 1 0.00 -0.97 0.06 0.65
Metastatic Breast Cancer 9,288 Disease Target Aurora B kinase 415 1 0.00 -1.00 0.00 0.58
Des (1-6) IGF-II 18 Target Target Collagen 138,882 1 0.00 -0.97 0.06 0.57
Metastatic Breast Cancer 9,288 Disease Target CEA 17,022 119 0.01 -0.99 0.01 0.65
Metastatic Breast Cancer 9,288 Disease Target ASK1 762 1 0.00 -1.00 0.00 0.56
CD148 74 Target Target Urokinase-Type Plasminogen Activator 3,939 1 0.00 -0.99 0.01 0.63
CD148 74 Target Target CD146 729 1 0.00 -0.99 0.01 0.68
CD148 74 Target Target Collagen 138,882 6 0.00 -0.96 0.08 0.58
CD148 74 Target Target CD95 4,266 2 0.00 -0.99 0.03 0.65
CD148 74 Target Target EGF 27,487 1 0.00 -0.99 0.01 0.58
CD148 74 Target Target Endoglin 1,333 1 0.00 -0.99 0.01 0.66
AMBP 160 Target Target Renin 43,456 2 0.00 -0.99 0.01 0.57
AMBP 160 Target Target AHSG 176 1 0.01 -0.99 0.01 0.72
AMBP 160 Target Target Collagen 138,882 1 0.00 -1.00 0.01 0.53
Metastatic Breast Cancer 9,288 Disease Target AKT2 873 5 0.00 -1.00 0.01 0.61
Metastatic Breast Cancer 9,288 Disease Target Calmodulin 25,240 1 0.00 -1.00 0.00 0.48
DAPK1 205 Target Target CD34 24,598 4 0.00 -0.99 0.02 0.60
DAPK1 205 Target Target CAMK4 43 1 0.01 -0.99 0.02 0.73
Metastatic Breast Cancer 9,288 Disease Target Aldosterone Receptor 528 1 0.00 -1.00 0.00 0.57
Metastatic Breast Cancer 9,288 Disease Target Cathepsin G 1,613 2 0.00 -1.00 0.00 0.57
Metastatic Breast Cancer 9,288 Disease Target Catechol O-Methyltransferase 2,877 1 0.00 -1.00 0.00 0.53
Sleep Apnea 18,342 Disease Target Cytokeratin 18 1,108 1 0.00 -1.00 0.00 0.54
DAPK1 205 Target Target CCL2 3,560 1 0.00 -1.00 0.00 0.62